<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0000842'>Hyperinsulinemia</z:hpo> in overweight status, <z:hpo ids='HP_0001513'>obesity</z:hpo>, and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) is often accompanied by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Gender is important in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> epidemiology, clinical presentation, and response to therapy in different histological types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Insufficient information is available concerning gender differences in DM with organ-specific and nonorgan-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This study aimed to analyze gender differences in hospitalized <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with or without type 2 DM </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We retrospectively reviewed ten years of patients hospitalized in one institution, enrolling 36,457 female and 50,004 male <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients of which 5,992 females and 8,345 males were diagnosed as type 2 DM </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Statistically significant increases in incidence of type 2 DM were found in patients of both genders with pancreatic, liver, and <z:e sem="disease" ids="C0751571" disease_type="Neoplastic Process" abbrv="">urinary tract cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Increased incidence of type 2 DM was found in lung and <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> in females and <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> in males </plain></SENT>
<SENT sid="7" pm="."><plain>Increases in mortality rates of females with type 2 DM (2.98%) were higher than those in males </plain></SENT>
<SENT sid="8" pm="."><plain>DM increased mortality rates in gender-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> from 1.91% (uterus, HR: 1.33) to 5.04% (ovary, HR: 1.49) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Type 2 DM increased mortality of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients of both genders, with higher increases in gender-specific than in nongender-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>